- Home
- TD vs BMY Comparison
TD vs BMY Comparison
Compare TD & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TD
- BMY
- Stock Information
- Founded
- TD 1855
- BMY 1887
- Country
- TD Canada
- BMY United States
- Employees
- TD N/A
- BMY 34100
- Industry
- TD
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- TD
- BMY Health Care
- Exchange
- TD Nasdaq
- BMY Nasdaq
- Market Cap
- TD 112.5B
- BMY 99.7B
- IPO Year
- TD N/A
- BMY N/A
- Fundamental
- Price
- TD $74.74
- BMY $47.92
- Analyst Decision
- TD Buy
- BMY Hold
- Analyst Count
- TD 2
- BMY 15
- Target Price
- TD $91.50
- BMY $58.93
- AVG Volume (30 Days)
- TD 2.1M
- BMY 12.4M
- Earning Date
- TD 08-21-2025
- BMY 07-31-2025
- Dividend Yield
- TD 3.98%
- BMY 5.07%
- EPS Growth
- TD 63.11
- BMY N/A
- EPS
- TD 6.97
- BMY 2.67
- Revenue
- TD $45,024,677,580.00
- BMY $47,636,000,000.00
- Revenue This Year
- TD $9.41
- BMY N/A
- Revenue Next Year
- TD $3.90
- BMY N/A
- P/E Ratio
- TD $10.74
- BMY $18.33
- Revenue Growth
- TD 20.69
- BMY 4.62
- 52 Week Low
- TD $51.25
- BMY $43.25
- 52 Week High
- TD $75.58
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- TD 62.12
- BMY 56.14
- Support Level
- TD $73.15
- BMY $46.57
- Resistance Level
- TD $75.58
- BMY $49.28
- Average True Range (ATR)
- TD 0.73
- BMY 1.02
- MACD
- TD -0.14
- BMY 0.25
- Stochastic Oscillator
- TD 63.35
- BMY 84.19
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 55% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 40% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.